Authors:
AVENT KM
RIKER RR
FRASER GL
VANDERSCHYF CJ
USUKI E
POND SM
Citation: Km. Avent et al., METABOLISM OF HALOPERIDOL TO PYRIDINIUM SPECIES IN PATIENTS RECEIVINGHIGH-DOSES INTRAVENOUSLY - IS HPTP AN INTERMEDIATE, Life sciences, 61(24), 1997, pp. 2383-2390
Citation: Rr. Riker et al., MOVEMENT-DISORDERS ASSOCIATED WITH WITHDRAWAL FROM HIGH-DOSE INTRAVENOUS HALOPERIDOL THERAPY IN DELIRIOUS ICU PATIENTS, Chest, 111(6), 1997, pp. 1778-1781
Authors:
FRASER GL
STOGSDILL P
DICKENS JD
WENNBERG DE
SMITH RP
PRATO BS
Citation: Gl. Fraser et al., ANTIBIOTIC OPTIMIZATION - AN EVALUATION OF PATIENT SAFETY AND ECONOMIC OUTCOMES, Archives of internal medicine, 157(15), 1997, pp. 1689-1694
Authors:
SCHMIDHAMMER H
JENNEWEIN HK
KRASSNIG R
TRAYNOR JR
PATEL D
BELL K
FROSCHAUER G
MATTERSBERGER K
JACHSEWINGER C
JURA P
FRASER GL
KALININ VN
Citation: H. Schmidhammer et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF 14-ALKOXYMORPHINANS .11. 3-HYDROXYCYPRODIME AND ANALOGS - OPIOID ANTAGONIST PROFILE IN COMPARISON TOCYPRODIME, Journal of medicinal chemistry, 38(16), 1995, pp. 3071-3077
Citation: Gl. Fraser et Cj. Fowler, KAPPA-OPIOID RECEPTOR RECOGNITION SITES ARE NOT MODULATED BY LOCAL-ANESTHETICS, Biochemical pharmacology, 49(7), 1995, pp. 883-891
Citation: Cj. Fowler et Gl. Fraser, MU-,DELTA-,KAPPA-OPIOID RECEPTORS AND THEIR SUBTYPES - A CRITICAL-REVIEW WITH EMPHASIS ON RADIOLIGAND BINDING EXPERIMENTS, Neurochemistry international, 24(5), 1994, pp. 401-426
Citation: Rr. Riker et al., CONTINUOUS-INFUSION OF HALOPERIDOL CONTROLS AGITATION IN CRITICALLY ILL PATIENTS, Critical care medicine, 22(3), 1994, pp. 433-440
Citation: Gl. Fraser et Rr. Riker, VISUAL COMPATIBILITY OF HALOPERIDOL LACTATE WITH INJECTABLE SOLUTIONS, American journal of hospital pharmacy, 51(7), 1994, pp. 905-906